| Revenue growth | Value |
|---|---|
| 3Y CAGR | +28% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +131% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,457.00 -55.50 (0.65%) | 21,301.50 | 113.59 | 24.41 | ||
PfizerPFIZER | ₹4,543.50 +50.00 (1.11%) | 20,590.83 | 28.5 | 4.9 | ||
₹1,434.50 +23.40 (1.66%) | 19,540.76 | 30.18 | 5.01 | |||
Granules IndiaGRANULES | ₹754.00 +12.60 (1.70%) | 18,365.47 | 30.87 | 3.61 |